Skip to content

Clinical trials

Completed Phase 1/2 Lymphoma, T-Cell, Peripheral trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Phase: Phase 1/2 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20063
20071
20083
20091
20113
20143
20151
20182
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
AbbVie (prior sponsor, Abbott)1
Acrotech Biopharma Inc.1
Aileron Therapeutics, Inc.1
Celgene1
Chonnam National University Hospital1
Dizal Pharmaceuticals1
Fondazione Italiana Linfomi - ETS1
Kyowa Kirin Co., Ltd.1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral21
Lymphoma, Non-Hodgkin8
Immunoblastic Lymphadenopathy7
Lymphoma, B-Cell, Marginal Zone6
Lymphoma, Follicular6
Lymphoma, Large-Cell, Anaplastic6
Lymphoma, Mantle-Cell6
Hodgkin Disease5
Lymphoma5
Lymphoma, Extranodal NK-T-Cell5

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.